Laura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies Group, has received a European Research Council (ERC) Adv...
Read moreThe study demonstrates that a specific genetic mutation (C122Y) in the Kir2.1 potassium channel alters the function not only of Kir2.1 but also of the main cardiac sodium channel NaV1.5, thus establis...
Read moreResearchers from Spain, Andorra and France have begun efforts to chart the biodiversity of microorganisms living under the surface of 300 different lakes across the Pyrenees. The initiative will shed ...
Read moreThe study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxic...
Read moreEsta patología afecta tanto a niños como a adultos y provoca la inflamación crónica de las vías respiratorias aéreas (fosas nasales, boca y faringe)
Read morePalobiofarma S.L. is pleased to announce the “last patient last visit” of the Phase II trial investigating the safety and preliminary efficacy of PBF-680 in moderate to severe COPD patients.
Read moreEl proyecto RiTA (Enfermedades Vasculares PortoSinusoidales: Estratificación de Riesgos y Enfoques Terapéuticos, por sus siglas en inglés), que ha empezado en abril 2024, tiene como objetivo princi...
Read moreLaminar Pharma opens a new financing round of up to seven million euros. The objective is to finish financing the development of its drug LAM561 against the most aggressive and common brain cancer, gl...
Read moreIt has been examined whether atherosclerosis can be avoided in HGPSrev mice by suppressing progerin and restoring lamin A either in endothelial cells or in vascular smooth muscle cells, two types of c...
Read more1.7 million, the project will run until the end of 2025 and will involve leading international institutions in the sector.
Read moreEl estudio PROBAC-EC demuestra que la estructura poblacional de la bacteria Escherichia coli en pacientes con infección grave es altamente compleja y que las características de virulencia y resisten...
Read moreAbren la posibilidad de explorar una nueva estrategia de modificación celular que puede ser enormemente atractiva para la próxima generación de medicamentos de terapia avanzada
Read more